Major side effects occur after coronary syndrome

Published Date: 13 Mar 2023

OSA itself predicted the incidence of MACCE in non-obese patients.

Read Full News

Latest News

GLP-1 RA Use May Improve Outcomes in HFrEF

In patients who have heart failure with reduced ejection fraction, GLP-1 receptor agonist use is associated with a lower risk for mortality and acute decompensated heart failure.

When Protecting Patients Conflicts With Telling the Truth

Physicians describe when delayed disclosure may be justified and why lying to patients is never ethically acceptable, even under family pressure.

Two Hair Loss Drugs Not Tied to Heart Disease Risk

Oral 5-alpha-reductase inhibitors do not increase the risk for cardiovascular disease in patients treated for androgenetic alopecia, study finds.

What Predicts Death After Surgery for Aortic Endocarditis?

Urgent surgery and preoperative haemodynamic instability strongly predict in-hospital death in native aortic valve endocarditis.

Early MCS May Improve Survival in Severe Cardiogenic Shock

Patients with severe cardiogenic shock benefit from early escalation to mechanical circulatory support, according to a recent study.

Pioneers Who Changed Clinical Practice

A soldier’s wound, a makeshift apartment lab and a risky self experiment: how curiosity, chance, and persistence led to discoveries that underpin today’s diagnostics and treatments.

Todays Updates

AstraZeneca to Invest $405 Million in Britain After US-UK Pharma Deal

Prime Minister Keir Starmer said on Wednesday that Britain's biggest company AstraZeneca would invest 300 million pounds ($405 ⁠million) in the country, after pausing...

Upadacitinib After TNF Inhibitor Failure Improves RA Control

In patients with active RA, switching to upadacitinib after failure of a single TNF inhibitor is more effective in reducing disease activity at 12 weeks than using a second TNF inhibitor adalimumab.

AAN 2026: Key RRMS Clinical Trial Updates

Dr Chu-Yueh Guo discusses promising MS trial results, including a study of fenebrutinib and positive safety data for ocrelizumab in pregnancy and pediatric patients.

Are Smartwatches Changing Arrhythmia Care?

Wearables can flag AF and capture symptoms in real time — but who truly benefits? Cardiologist Walid Amara, MD, outlines where smartwatches fit in clinical practice.

Why the FDA Rejected RP-1 in Melanoma: A Data Deep Dive

Dr Bishal Gyawali unpacks the FDA’s decision to deny RP-1 in melanoma, exploring why single-arm data and confounded response rates failed to meet the bar for clinical evidence.

Differential Diagnosis of Suspected Pulmonary Fibrosis and Efficacy of Approved Therapies

Experts review the differential diagnosis of suspected IPF, highlighting how a multidisciplinary approach confirmed the diagnosis and informed selection of optimal antifibrotic therapy.

‘Living’ Database Tracks Psilocybin Trials for Depression

Sypres.io continuously tracks and evaluates psychedelic research, offering an up-to date view of study findings, design, and limitations.

Todays Updates

AstraZeneca to Invest $405 Million in Britain After US-UK Pharma Deal

Prime Minister Keir Starmer said on Wednesday that Britain's biggest company AstraZeneca would invest 300 million pounds ($405 ⁠million) in the country, after pausing...

Upadacitinib After TNF Inhibitor Failure Improves RA Control

In patients with active RA, switching to upadacitinib after failure of a single TNF inhibitor is more effective in reducing disease activity at 12 weeks than using a second TNF inhibitor adalimumab.

AAN 2026: Key RRMS Clinical Trial Updates

Dr Chu-Yueh Guo discusses promising MS trial results, including a study of fenebrutinib and positive safety data for ocrelizumab in pregnancy and pediatric patients.

Are Smartwatches Changing Arrhythmia Care?

Wearables can flag AF and capture symptoms in real time — but who truly benefits? Cardiologist Walid Amara, MD, outlines where smartwatches fit in clinical practice.

Why the FDA Rejected RP-1 in Melanoma: A Data Deep Dive

Dr Bishal Gyawali unpacks the FDA’s decision to deny RP-1 in melanoma, exploring why single-arm data and confounded response rates failed to meet the bar for clinical evidence.

Differential Diagnosis of Suspected Pulmonary Fibrosis and Efficacy of Approved Therapies

Experts review the differential diagnosis of suspected IPF, highlighting how a multidisciplinary approach confirmed the diagnosis and informed selection of optimal antifibrotic therapy.

‘Living’ Database Tracks Psilocybin Trials for Depression

Sypres.io continuously tracks and evaluates psychedelic research, offering an up-to date view of study findings, design, and limitations.

Latest News

In patients who have heart failure with reduced ejection fraction, GLP-1 receptor agonist use is associated with a lower risk for mortality and acute decompensated heart failure.

Physicians describe when delayed disclosure may be justified and why lying to patients is never ethically acceptable, even under family pressure.

Oral 5-alpha-reductase inhibitors do not increase the risk for cardiovascular disease in patients treated for androgenetic alopecia, study finds.

Urgent surgery and preoperative haemodynamic instability strongly predict in-hospital death in native aortic valve endocarditis.

Patients with severe cardiogenic shock benefit from early escalation to mechanical circulatory support, according to a recent study.

A soldier’s wound, a makeshift apartment lab and a risky self experiment: how curiosity, chance, and persistence led to discoveries that underpin today’s diagnostics and treatments.

News All Time

Eugene Braunwald, Cardiology Pioneer, Dies at 96

Eugene Braunwald transformed cardiovascular medicine through seven decades of groundbreaking research, clinical trials, and mentorship that saved countless lives.

Home Training Boosts Fitness in Repaired Tetralogy of Fallot

High intensity interval training boosts exercise capacity in adolescents and young adults with repaired tetralogy of Fallot, without causing harmful changes in heart structure or function.

Europe Trusts Medicine, but Trust Alone Isn't Enough

Trust in medicine remains high across Europe, but researchers say the bigger challenge is making medical knowledge clear, relevant, and actionable.

FDA-Approved System Tracks Cardiogenic Shock in Real Time

Software tool continuously monitors patients based on SCAI cardiogenic shock classification.

Statins May Lower Risk for Strictures in Crohn’s Disease

Use of statins after the diagnosis of Crohn’s disease is associated with a lower risk for intestinal stricture formation than the use of other non-statin drugs.

Trial Data May Shift Coronary Artery Disease Treatment

Emerging evidence may help reshape antiplatelet and lipid strategies for the management of coronary artery disease.

Refined Grains May Not Be Good for People With Heart Failure

Eating more than three servings of refined grains per day was associated with a greater risk for adverse clinical outcomes in people with heart failure vs diets focusing on vegetables and legumes.

Competing Stroke Causes Common in AF Despite Anticoagulation

Nearly 1 in 4 patients with atrial fibrillation who experience an ischaemic stroke despite oral anticoagulation have additional competing stroke aetiologies.

Loneliness Tied to Degenerative Valvular Heart Disease Risk

Loneliness is linked to an increased risk for degenerative valvular heart disease and could be a modifiable risk factor for at-risk patients.

One Pill, Three Meds, Fewer Strokes After ICH

Final results of the TRIDENT trial show that a single pill containing low doses of three different antihypertensives dramatically reduces recurrent stroke in patients with ICH.

Waist Size Can Signal Risk for Heart Disease in T1D

A higher waist-to-height ratio is independently linked to an increased risk for coronary artery disease in patients with type 1 diabetes, according to a 19-year cohort study.

Poor Muscle Composition Tied to Mortality in Kidney Disease

Adverse muscle composition is independently associated with an increased risk for all-cause mortality in patients with chronic kidney disease, a UK-based study finds.

His Cancer Diagnosis in Medical School Changed Everything

A childhood diagnosis inspired Hunter Bohon to go into medicine. A cancer diagnosis at 26 changed what kind of doctor he wants to be.

Challenges of Placebo Arms in Weight-Loss Drug Trials

Drugmakers continue to test weight-loss medicines against dummy pills and shots, even with a growing number of effective approved obesity drugs. This practice raises practical questions.

FXIa Inhibitor Hits Mark in Recurrent Stroke Prevention

Full results from the OCEANIC-STROKE trial show a 26% reduction in recurrent stroke with the factor XIa inhibitor asundexian, with no increased bleeding risk.

One-Month Limit Imposed on Ramipril 1.25-mg Supplies

New shortage protocol allows UK pharmacists to restrict dispensing as supply pressures hit a drug used by millions.

Recommended News For You

Formaldehyde releasers found in common personal care products used especially by Black and Latina women

Glioblastoma treatment breakthrough shows promise

The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.

RML to develop bone marrow transplantation at Lady Hardinge Medical College in Safdarjung

Detecting pancreatic cancer through changes in body composition and metabolism

An inadvertent loss of weight may be an indication to consult a physician, according to research.

Video: Liver transplant for patients with advanced colorectal cancer

Recommended Articles For You

The Unseen Threat: Uncovering the Risks of Pancoast Tumor 

AI Revolutionizes Immunotherapy: Unveiling Biomarkers with Machine Intelligence 

Cardio-Oncology: Managing Heart Failure in Survivors of Cancer 

Beating Cancer Fatigue The Most Effective Exercise Strategies for Breast Cancer Survivors 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

NIH research cuts leave cancer patient facing hard choice

2.

When BCG is not effective in treating bladder cancer, Oncolytic Virus exhibits high response rates.

3.

A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.

4.

For treatment, the majority of cancer patients choose complementary therapies.

5.

Implant-based reconstruction linked to increased risk of breast lymphomas

1.

Understanding Adenomyosis: The Role of Ultrasound in Diagnosis Introduction

2.

Exploring the Benefits of Teclistamab for Treating Advanced Cancer

3.

HPV and Immunotherapy in Cancer Survivorship: National Cancer Survivors Day Review

4.

Navigating the Complexities of Melanoma Staging: A Comprehensive Guide

5.

Liquid Biopsies and ctDNA: Transforming Cancer Detection, Monitoring, and Clinical Decisions

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer

2.

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

3.

Navigating the Complexities of Ph Negative ALL - Part IX

4.

Efficient Management of First line ALK-rearranged NSCLC

5.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot